Ship Healthcare Holdings has authorized a buyback of up to 3.3 million shares, with a total spending ceiling of ¥5 billion. The company said that amounts to 3.6% of shares outstanding excluding treasury stock. The repurchase window runs from June 8 to December 31 and will be carried out through market purchases on the Tokyo Stock Exchange.
| Feature | Detail |
|---|---|
| Maximum shares | 3.3 million shares |
| Share of outstanding stock | 3.6% of shares outstanding excluding treasury stock |
| Maximum spend | ¥5 billion |
| Purchase window | June 8, 2026 to December 31, 2026 |
| Method | Market purchases on the Tokyo Stock Exchange |
| Stated purpose | Strengthen shareholder returns and improve capital efficiency as part of medium-term plan capital policy |
| Treasury shares already held | 2,331,200 shares as of March 31, 2026 |
| Shares outstanding excluding treasury | 94,350,134 shares as of March 31, 2026 |
Management framed the move as part of the capital policy in the medium-term management plan it announced on May 13, saying the aim is to strengthen shareholder returns and improve capital efficiency. It also said it intends to keep balancing growth investment and shareholder returns while pursuing a sustained increase in corporate value.
For readers trying to judge the capital-allocation signal, the useful feature is the structure of the authorization. Ship has set a hard limit on cash outlay, a hard limit on shares and a fixed end date. That does not reveal how much of the envelope will ultimately be used. It does, however, turn a general promise about shareholder returns and capital efficiency into a program with measurable limits.
The disclosure also gives a baseline. As of March 31, the company held 2,331,200 treasury shares and had 94,350,134 shares outstanding excluding treasury stock. What remains uncertain is execution. The company has authorized a program, not reported completed purchases, so the ceiling is known today but the actual repurchase total is not.